Brains Bioceutical Corp. (“Brains Bio”), a global life sciences company advancing a clinically validated portfolio of therapeutic and pharmaceutical programs, today announced the appointment of Dr.
Google's new API key architecture has come under scrutiny due to significant security flaws that potentially expose user data ...
The device could help address multiple neurological conditions if it proves successful. One early use could be delivering ...
In sterile barrier packaging, failure rarely announces itself clearly. It appears as an intermittent tear instead of a clean ...
Kumo Launches KumoRFM-2, A Foundation Model Built to Replace Traditional Enterprise Machine Learning
Kumo has unveiled KumoRFM-2, a next-generation foundation model designed specifically for structured enterprise data—marking ...
Meta debuted its first major large language model, Muse Spark, spearheaded by chief AI officer Alexandr Wang, who leads Meta ...
By laying the genetic risk signals over their new cell atlas, the team found the answers. They discovered that preeclampsia ...
The advent of immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized oncology. However, a significant proportion of patients ...
Peter Steinberger, the creator of OpenClaw, faces challenges as AI firm Anthropic blocks its Claude models from integrating with his third-party agent tool.
South Korean researchers have developed a method to bypass a fundamental limitation in biosensors, a step that could ...
An electrochemical sensor developed at Oregon State University holds promise for making food quality testing faster, more ...
A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results